NewcelX Ltd.(NCEL)

Biotechnology · Kloten, ZH

$2.96+0.10 (+3.52%)

Delayed quote: Oct 6, 2026, 3:13 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T19:42:33.050Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:42:33.050Z.

Quote observation: 2026-10-06T19:13:53.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,332,315
Total debt · period ending 2026-06-30: 392,000
Cash · period ending 2026-06-30: 710,000
TTM operating EBITDA · period ending 2026-06-30: N/A

FMP input reference: ceb9d7bb150905ac81611c4688aa1bd793b2f4eb464ba4dc05e218b0340a6d90

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NCEL EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

NCEL Competitors' EV/EBITDA Ratio

NCEL

NewcelX Ltd.

Current

Market Cap

$1.33M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GNPX

Genprex, Inc.

vs NCEL

Market Cap

$1.33M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARTL

Artelo Biosciences, Inc.

vs NCEL

Market Cap

$1.32M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JUNS

Jupiter Neurosciences, Inc.

vs NCEL

Market Cap

$1.34M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IVF

INVO Fertility, Inc.

vs NCEL

Market Cap

$1.42M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NXGL

NEXGEL, Inc.

vs NCEL

Market Cap

$1.45M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELAB

PMGC Holdings Inc.

vs NCEL

Market Cap

$1.48M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRIS

Curis, Inc.

vs NCEL

Market Cap

$1.48M

EV/EBITDA Ratio

N/A

TTM Avg

341.73x

3Y Avg

341.73x

5Y Avg

341.73x

LABT

Lakewood-Amedex Biotherapeutics, Inc.

vs NCEL

Market Cap

$1.51M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMCC

IM Cannabis Corp.

vs NCEL

Market Cap

$1.14M

EV/EBITDA Ratio

N/A

TTM Avg

18.93x

3Y Avg

18.93x

5Y Avg

18.93x

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
NewcelX Ltd. (NCEL)	$1.33M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.33M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.32M	N/A	N/A	N/A	N/A
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.34M	N/A	N/A	N/A	N/A
INVO Fertility, Inc. (IVF)vs ›	$1.42M	N/A	N/A	N/A	N/A
NEXGEL, Inc. (NXGL)vs ›	$1.45M	N/A	N/A	N/A	N/A
PMGC Holdings Inc. (ELAB)vs ›	$1.48M	N/A	N/A	N/A	N/A
Curis, Inc. (CRIS)vs ›	$1.48M	N/A	341.73x	341.73x	341.73x
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.51M	N/A	N/A	N/A	N/A
IM Cannabis Corp. (IMCC)vs ›	$1.14M	N/A	18.93x	18.93x	18.93x

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics